Kirsten has over 15 years of experience in clinical and genetic epidemiology. Kirsten leads the clinical studies and biostatistics team at Proteomics International, responsible for the development and validation of Promarker®D and diagnostics in the Promarker® pipeline. She has been with the company for over 10 years and has been a Consultant at the University of Western Australia for 15 years. Kirsten has extensive experience in data analysis and has co-authored over 40 peer-reviewed journal articles. Qualifications PhD (Research), Medical Sciences, JCSMR, ANU, Australia BSc with honours in Medical Sciences, UON, Australia BSc in Molecular Biology and Medical Sciences, UON, Australia